Cryo-Save Group N.V. (Euronext: CRYO, `Cryo-Save`, or `the Group`), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces today that it has convened its annual general meeting of shareholders (`AGM`) to be held on Wednesday 14 May 2014 at 14:00 hours CET at the Hilton Amsterdam Airport Schiphol, Schiphol Boulevard 701, 1118 BN Schiphol, the Netherlands.
The notice, agenda, the explanatory notes thereto and the annual report 2013 will be available for inspection and can be acquired at no costs at our offices and at Kempen & Co N.V. (Beethovenstraat 300, 1077 WZ Amsterdam, facsimile +31 (0)20 348 95 49, email: firstname.lastname@example.org). These documents can also be downloaded from www.cryo-save.com/group.
|Cryo-Save Group||+ 31 (0) 575 548 998|
|Frédéric Amar, Chief Executive Officer|
About Cryo-Save (www.cryo-save.com/group)
Cryo-Save, the leading international family stem cell bank, stores more than 250,000 samples from umbilical cord blood and cord tissue. There are already many diseases treatable by the use of stem cells, and the number of treatments will only increase. Cryo-Save has cryopreserved samples from over 70 countries on six continents, with ultra-modern processing and storage facilities in Belgium, Germany, Dubai, and South Africa.
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Cryo-Save Group N.V. via GlobeNewswire